Tenogenic differentiation of equine mesenchymal progenitor cells under indirect co-culture

International Journal of Artificial Organs

Volumn 35, Issue 11, 2012, Pages 996-1005

  Lovati, Arianna B ^a,c   Corradetti, Bruna ^b   Cremonesi, Fausto ^a   Bizzaro, Davide ^b   Consiglio, Anna Lange ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Co culture; Equine; Gene expression; Mesenchymal stem cells; Tendon; Tissue engineering

Indexed keywords

CELL ENGINEERING; FLOWCHARTING; GENE EXPRESSION; POLYMERASE CHAIN REACTION; STEM CELLS; TENDONS; TISSUE ENGINEERING;

BONE MARROW MESENCHYMAL; CELL-BE; CELL/B.E; CO-CULTURES; EQUINE; GENES EXPRESSION; MARROW MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; TENOGENIC; TISSUES ENGINEERINGS;

CELL CULTURE;

COLLAGEN TYPE 1; DECORIN; TENASCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOCHEMISTRY; GENE EXPRESSION; HORSE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENDON;

EID: 84871870461     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000129     Document Type: Article

References (57)

1. Goodship AE, Birch HL, Wilson AM. The pathobiology and repair of tendon and ligament injury. Vet Clin north Am Equine Pract. 1994; 10(2):323-349.
2. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse. Equine Vet J. 2000; 32(5):369-378.
3. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J. 2004;36(5):415-419.
4. Kasashima Y, Takahashi T, Smith RK, et al. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999. Equine Vet J. 2004; 36(4):346-350.
5. Pufe T, Petersen WJ, Mentlein R, Tillmann Bn. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand J Med Sci Sports. 2005; 15(4): 211-222.
6. Kannus P. Structure of the tendon connective tissue. Scand J Med Sci Sports. 2000; 10(6):312-320.
7. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J. 2003; 35(1):99-102.
8. Butler DL, Juncosa-Melvin n, Boivin G P, et al. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res. 2008; 26(1):1-9.
9. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine Vet J. 2008; 40(2):178-181.
10. Awad HA, Boivin G P, Dressler MR, Smith Fn, Young RG, Butler DL. Repair of patellar tendon injuries using a cell-collagen composite. J Orthop Res. 2003; 21(3):420-431.
11. Ouyang HW, Goh JC, Thambyah A, Teoh SH, Lee EH. Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon. Tissue Eng. 2003; 9(3):431-439.
12. Ouyang HW, Goh JC, Lee EH. Viability of allogeneic bone marrow stromal cells following local delivery into patella tendon in rabbit model. Cell Transplant. 2004; 13(6): 649-657.
13. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res. 1998; 16(4):406-413.
14. Harris MT, Butler DL, Boivin G P, Florer JB, Schantz EJ, Wenstrup RJ. Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs. J Orthop Res. 2004; 22(5):998-1003.
15. Bruder S P, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994; 56(3):283-294.
16. Pittenger M F, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-147.
17. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007; 213(2):341-347.
18. Huss R. Isolation of primary and immortalized CD34-hema-topoietic and mesenchymal stem cells from various sources. Stem Cells. 2000; 18(1):1-9.
19. Barry F P, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004; 36(4):568-584.
20. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM, Gimble JM. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesen-chymal stromal cells: adipogenic and osteogenic capacity. Vet Surg. 2006; 35(7):601-610.
21. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stro-mal cells. Vet Surg. 2007; 36(7):613-622.
22. Arnhold SJ, Goletz I, Klein H, et al. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res. 2007; 68(10):1095-1105.
23. Hayashi O, Katsube Y, Hirose M, Ohgushi H, Ito H. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int. 2008; 82(3):238-247.
24. Titushkin I, Sun S, Shin J, Cho M. Physicochemical control of adult stem cell differentiation: shedding light on potential molecular mechanisms. J Biomed Biotechnol. 2010; 2010:743-476.
25. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11):2739-2749.
26. Woo SL, Hildebrand K, Watanabe n, Fenwick JA, Papa-georgiou CD, Wang JH. Tissue engineering of ligament and tendon healing. Clin Orthop Relat Res. 1999;(367 Suppl):S312-S323.
27. Lee IC, Wang JH, Lee YT, Young TH. The differentiation of mesenchymal stem cells by mechanical stress or/ and co-culture system. Biochem Biophys Res Commun. 2007; 352(1):147-152.
28. Ku CH, Johnson PH, Batten P, et al. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res. 2006; 71(3):548-556.
29. Hwang NS, Varghese S, Elisseeff J. Derivation of chon-drogenically-committed cells from human embryonic cells for cartilage tissue regeneration. PLoS One. 2008; 3(6): e2498.
30. Violini S, Ramelli P, Pisani L F, Gorni C, Mariani P. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol. 2009; 10:29.
31. Hankemeier S, Keus M, Zeichen J, et al. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments. Tissue Eng. 2005; 11(1-2):41-49.
32. Farng E, Urdaneta AR, Barba D, Esmende S, McAllister DR. The effects of GDF-5 and uniaxial strain on mesen-chymal stem cells in 3-D culture. Clin Orthop Relat Res. 2008; 466(8):1930-1937.
33. Liu C F, Aschbacher-Smith L, Barthelery nJ, Dyment n, Butler D, Wylie C. What we should know before using tissue engineering techniques to repair injured tendons: a developmental biology perspective. Tissue Eng Part B Rev. 2011; 17(3):165-176.
34. Csaki C, Matis U, Mobasheri A, Shakibaei M. Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation. Histochem Cell Biol. 2009; 131(2):251-266.
35. Chen WH, Lai MT, Wu AT, et al. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum. 2009; 60(2):450-459.
36. Zhang L, Tran N, Chen HQ, et al. Time-related changes in expression of collagen types I and III and of tenascin-C in rat bone mesenchymal stem cells under co-culture with ligament fibroblasts or uniaxial stretching. Cell Tissue Res. 2008; 332(1):101-109.
37. Wang T, Xu Z, Jiang W, Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol. 2006; 109(1):74-81.
38. Ball SG, Shuttleworth AC, Kielty CM. Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol. 2004; 36(4):714-727.
39. Luo Q, Song G, Song Y, Xu B, Qin J, Shi Y. Indirect co-culture with tenocytes promotes proliferation and mRnA expression of tendon/ligament related genes in rat bone marrow mesenchymal stem cells. Cytotechnology. 2009; 61(1-2):1-10.
40. Chiquet-Ehrismann R, Tucker R P. Connective tissues: signalling by tenascins. Int J Biochem Cell Biol. 2004; 36(6): 1085-1089.
41. Bullough R, Finnigan T, Kay A, Maffulli n, Forsyth nR. Tendon repair through stem cell intervention: cellular and molecular approaches. Disabil Rehabil. 2008; 30(20-22): 1746-1751.
42. Docheva D, Hunziker EB, Fässler R, Brandau O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol. 2005; 25(2):699-705.
43. Shukunami C, Takimoto A, Oro M, Hiraki Y. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol. 2006; 298(1): 234-247.
44. Lovati AB, Corradetti B, Lange Consiglio A, et al. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells. Vet Res Commun. 2011; 35(2):103-121.
45. Mizuno N, Ozeki Y, Shiba H, et al. Humoral factors released from human periodontal ligament cells influence calcification and proliferation in human bone marrow mesenchymal stem cells. J Periodontol. 2008; 79(12): 2361-2370.
46. Wong MW, Lui WT, Fu SC, Lee KM. The effect of glucocorti-coids on tendon cell viability in human tendon explants. Acta Orthop. 2009; 80(3):363-367.
47. Schweitzer R, Chyung JH, Murtaugh LC, et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001; 128(19): 3855-3866.
48. Léjard V, Brideau G, Blais F, et al. Scleraxis and nFATc regulate the expression of the Pro-α1 (I) Collagen gene in tendon fibroblasts. J Biol Chem. 2007; 282: 17666-17675.
49. Aslan H, Kimelman-Bleich n, Pelled G, Gazit D. Molecular targets for tendon neoformation. J Clin Invest. 2008; 118(2): 439-444.
50. Shukunami C, Oshima Y, Hiraki Y. Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Bio-chem Biophys Res Commun. 2001; 280(5):1323-1327.
51. Shukunami C, Oshima Y, Hiraki Y. Chondromodulin-I and te-nomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun. 2005; 333(2):299-307.
52. Oshima Y, Shukunami C, Honda J, et al. Expression and localization of tenomodulin, a transmembrane type chon-dromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci. 2003; 44(5):1814-1823.
53. Lee JY, Zhou Z, Taub PJ, et al. BMP-12 treatment of adult mesenchymal stem cells in vitro augments tendonlike tissue formation and defect repair in vivo. PLoS One. 2011; 6(3):e17531.
54. Murchison ND, Price BA, Conner DA, et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development. 2007; 134(14):2697-2708.
55. Hsia HC, Schwarzbauer JE. Meet the tenascins: multifunctional and mysterious. J Biol Chem. 2005; 280(29): 26641-26644.
56. Maeda T, Sakabe T, Sunaga A, et al. Conversion of mechanical force into TGF-β-mediated biochemical signals. Curr Biol. 2011; 21(11):933-941.
57. Lovati AB, Corradetti B, Lange Consiglio A, et al. Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents. 2011; 25(2) (Suppl):S75-S84.